Tetraphase Pharmaceuticals competitive analysis

Latest publications and patents of Tetraphase Pharmaceuticals New

Explore the latest publications and patents granted to Tetraphase Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Tetraphase Pharmaceuticals

Oct 18, 2017C7-Fluoro Substituted Tetracycline CompoundsRevoked

Explore patent oppositions filed by Tetraphase Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Crystalline Eravacycline Bis-HydrochlorideSANDOZJun 22, 2021

Explore Tetraphase Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 18, 2017C7-Fluoro Substituted Tetracycline Compounds1

Latest PTAB cases involving Tetraphase Pharmaceuticals

Discover the latest PTAB cases involving Tetraphase Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tetraphase Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
TETRAPHASE PHARMACEUTICALS11 - - Aggressive
SANDOZ1141519 - Highly Aggressive